Chronic lymphocytic leukemia - aiming at a moving target!

被引:0
作者
Hillmen, Peter [1 ]
机构
[1] Leeds Gen Infirm, Dept Hematol, Great George St, Leeds LS1 3EX, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1451 / 1452
页数:2
相关论文
共 13 条
[1]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[2]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[3]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[4]   Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia [J].
Fält, S ;
Merup, M ;
Tobin, G ;
Thunberg, U ;
Gahrton, G ;
Rosenquist, R ;
Wennborg, A .
BLOOD, 2005, 106 (02) :681-689
[5]   Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia [J].
Hamblin, TJ ;
Davis, Z ;
Gardiner, A ;
Oscier, DG ;
Stevenson, FK .
BLOOD, 1999, 94 (06) :1848-1854
[6]  
Johnson TA, 1997, J IMMUNOL, V158, P235
[7]   In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells [J].
Messmer, BT ;
Messmer, D ;
Allen, SL ;
Kolitz, JE ;
Kudalkar, P ;
Cesar, D ;
Murphy, EJ ;
Koduru, P ;
Ferrarini, M ;
Zupo, S ;
Cutrona, G ;
Damle, RN ;
Wasil, T ;
Rai, KR ;
Hellerstein, MK ;
Chiorazzi, N .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :755-764
[8]   Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival [J].
Moreton, P ;
Kennedy, B ;
Lucas, G ;
Leach, M ;
Rassam, SMB ;
Haynes, A ;
Tighe, L ;
Oscier, D ;
Fegan, C ;
Rawstron, A ;
Hillmen, P .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2971-2979
[9]   ZAP-70 expression and prognosis in chronic lymphocytic leukaemia [J].
Orchard, JA ;
Ibbotson, RE ;
Davis, Z ;
Wiestner, A ;
Rosenwald, A ;
Thomas, PW ;
Hamblin, TJ ;
Staudt, LM ;
Oscier, DG .
LANCET, 2004, 363 (9403) :105-111
[10]   ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia [J].
Rassenti, LZ ;
Huynh, L ;
Toy, TL ;
Chen, L ;
Keating, MJ ;
Gribben, JG ;
Neuberg, DS ;
Flinn, IW ;
Rai, KR ;
Byrd, JC ;
Kay, NE ;
Greaves, A ;
Weiss, A ;
Kipps, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (09) :893-901